Finucane Anne A. 4
4 · CVS HEALTH Corp · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Finucane Anne A.
Director
Transactions
- Award
Deferred Stock Units
2024-11-21$57.10/sh+2,200.088$125,625→ 12,173.164 totalExercise: $0.00→ Common Stock (2,200.088 underlying)
Holdings
- 7,232.248
Common Stock
- 25,198(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- [F2]Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.